Chemistry:Istiratumab

From HandWiki
Revision as of 01:55, 27 June 2023 by John Stpola (talk | contribs) (correction)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Short description: Monoclonal antibody
Istiratumab
Monoclonal antibody
Type?
SourceHuman
TargetIGF1R, ErbB3
Clinical data
Other namesMM-141
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
KEGG
Chemical and physical data
FormulaC8802H13532N2392O2796S58
Molar mass199458.51 g·mol−1

Istiratumab (MM-141) is an experimental monoclonal antibody for the treatment of cancer. It is a bispecific antibody targeting IGF-1R and ErbB3.[1]

It is in development by Merrimack Pharmaceuticals and was awarded orphan drug status for pancreatic cancer.[2]

References